DECIDE Study: Shared decision making for treatment at discharge with schizophrenic inpatients

DECIDE Study: Effectiveness of shared decision making in the choice of antipsychotic treatment at discharge from a hospitalization after an acute episode in schizophrenic patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN36203678

Enrollment

120

Registered

2016-07-06

Start date

2014-03-01

Completion date

Unknown

Last updated

2022-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia and schizoaffective disorders Mental and Behavioural Disorders Schizophrenia and schizoaffective disorders

Interventions

Following provision of informed consent, participants are randomly allocated to one of two groups. Shared decision making (SDM) group: Participants receive the SDM program which is de

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients aged 18 years and over 2. Diagnosed of schizophrenia (ICD-10: F20) or schizoaffective disorder (ICD-10: F.25) 3. Admitted to Jerez Adult Psychiatric Hospitalization Unit 4. Prescribed antipsychotic medication at discharge

Exclusion criteria

Exclusion criteria: 1. Patients who refuse to sign informed consent 2. Patients who lack capacity in the moment of entering the study,as measured by the Aid to Capacity Evaluation (ACE) 3. Patients with a comorbid diagnosis of severe or moderate mental retardation 4. Patients with poor knowledge or communication skills in Spanish

Design outcomes

Primary

Measure	Time frame
Antipsychotic treatment adherence is measured using the Brief Adherence Rating Scale (BARS) and the Drug Attitude Inventory (DAI) at baseline, 3, 6 and 12 months	—

Secondary

Measure	Time frame
1. Readmission rate is measured through medical record review at 3, 6 and 12 months 2. Quality of doctor-patient relationship measured using the Working Alliance Inventory Short Version (WAI-S) at baseline, 3, 6 and 12 months 3. Patient satisfaction with intervention and confidence on decision taken is measured using the Combined Outcome Measure Communication and Treatment Decision making Effectiveness Scale (COMRADE Scale) at baseline, 3, 6 and 12 months 4. Patient perception of hospitalization is measured using the Picker Patient Experience Questionnaire (PPE-15) at discharge	—

Measure

Time frame

1. Readmission rate is measured through medical record review at 3, 6 and 12 months 2. Quality of doctor-patient relationship measured using the Working Alliance Inventory Short Version (WAI-S) at baseline, 3, 6 and 12 months 3. Patient satisfaction with intervention and confidence on decision taken is measured using the Combined Outcome Measure Communication and Treatment Decision making Effectiveness Scale (COMRADE Scale) at baseline, 3, 6 and 12 months 4. Patient perception of hospitalization is measured using the Picker Patient Experience Questionnaire (PPE-15) at discharge

—

Countries

Spain

Contacts

Public ContactJosé Ildefonso Pérez-Revuelta

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026